Compounds > erythrosine

erythrosine and chromates

erythrosine has been researched along with chromates in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunne, CP; Porter, WL; Whitburn, KD1
Chuang, SM; Liou, GY; Yang, JL1
Messer, J; Shrager, S; Zhitkovich, A1
Martin, BD; Rigby, KM; Sugden, KD1
Jokar, F; O'brien, PJ; Pourahmad, J; Rabiei, M1
DeLoughery, Z; Luczak, MW; Zhitkovich, A1

Other Studies

6 other study(ies) available for erythrosine and chromates

ArticleYear
Biphasic protonation of hydrophilic cargo agents in unilamellar phospholipid vesicles: implications about cargo location.
    Biochimica et biophysica acta, 1994, Oct-06, Volume: 1214, Issue:3

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Chromates; Fluoresceins; Hydrogen-Ion Concentration; Liposomes; Protons; Spectrophotometry, Ultraviolet; Water

1994
Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
    Carcinogenesis, 2000, Volume: 21, Issue:8

    Topics: Adenocarcinoma; Amitrole; Catalase; Cell Division; Chelating Agents; Chromates; Drug Interactions; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Flavonoids; Fluoresceins; Fluorescent Dyes; Free Radical Scavengers; Humans; Hydrogen Peroxide; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Mannitol; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Potassium Compounds; Pyridines; Tumor Cells, Cultured

2000
Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
    Chemical research in toxicology, 2000, Volume: 13, Issue:11

    Topics: Animals; Buffers; Cations; Cattle; Chromates; Chromium Compounds; Cysteine; DNA Adducts; DNA Damage; DNA, Superhelical; Drug Stability; Fluoresceins; Fluorescent Dyes; Hydrogen-Ion Concentration; Kinetics; Oxidation-Reduction; Reducing Agents

2000
Oxidative activation of the human carcinogen chromate by arsenite: a model for synergistic metal activation leading to oxidative DNA damage.
    Toxicology in vitro : an international journal published in association with BIBRA, 2004, Volume: 18, Issue:6

    Topics: Arsenites; Carcinogens, Environmental; Chromates; Chromium; DNA Damage; Drug Interactions; Fluoresceins; Fluorescence; Models, Theoretical; Oxidation-Reduction; Oxidative Stress

2004
A comparison of hepatocyte cytotoxic mechanisms for chromate and arsenite.
    Toxicology, 2005, Jan-31, Volume: 206, Issue:3

    Topics: Animals; Arsenites; Cell Survival; Chromates; Fluoresceins; Fluorometry; Free Radical Scavengers; Glutathione; Hepatocytes; Lipid Peroxides; Lysosomes; Male; Membrane Potentials; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rhodamine 123; Thiobarbituric Acid Reactive Substances

2005
Monitoring Cr intermediates and reactive oxygen species with fluorescent probes during chromate reduction.
    Chemical research in toxicology, 2014, May-19, Volume: 27, Issue:5

    Topics: Ascorbic Acid; Cell Line; Chromates; Epithelial Cells; Fluoresceins; Fluorescent Dyes; Glutathione; Humans; Oxidation-Reduction; Reactive Oxygen Species; Rhodamines

2014